# Amundi Index Solutions - MSCI Europe UCITS ETF DR (CEG2)

**Page:** https://fundology.uk/fund/ceg2 · ISIN LU1437015735

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 13/11/2026, CEG2 (Amundi Index Solutions - MSCI Europe UCITS ETF DR, ISIN LU1437015735) closed at £106.83 on the London Stock Exchange. Its ongoing charge is 0.15% a year (about £15 on £10,000). Over the five years to 13/11/2026 its total return was +55.4%, or +21.3% after UK CPIH inflation.

## Summary

Amundi Index Solutions - MSCI Europe UCITS ETF DR is an exchange-traded fund (ETF) from Amundi, launched in 2016. It tracks the MSCI Europe Index - EUR - Benchmark TR Net — large and medium-sized European companies. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.15% a year — about £15 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Latest close: **£106.83** (13/11/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | CEG2 |
| ISIN | LU1437015735 |
| Also listed as | CEU2 (London Stock Exchange, US dollars) |
| Category | European shares |
| Type | ETF |
| Provider | Amundi |
| Tracks | MSCI Europe Index - EUR - Benchmark TR Net |
| Income | Accumulating |
| Ongoing charge | 0.15% a year (£15 per £10,000) |
| Fund size | £3.6bn |
| Launched | 2016 |
| Domicile | Luxembourg |
| UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 31/10/2016 |

## Past returns (periods to 13/11/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +10.47% | +6.56% | income reinvested |
| 3 years | +52.68% | +37.94% | income reinvested |
| 5 years | +55.42% | +21.31% | income reinvested |

Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of Amundi Index Solutions - MSCI Europe UCITS ETF DR in pounds (price, with income reinvested in the fund): 2023 +13.2%, 2024 +4.0%, 2025 +26.2%; 2026 to 13/11/2026 +9.8%. Returns of Amundi Index Solutions - MSCI Europe UCITS ETF DR in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +12.3%; to 30/09/2025: +15.8%; to 30/09/2024: +15.5%; to 30/09/2023: +18.0%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2023 | +13.2% | +8.7% | Price |
| 2024 | +4.0% | +0.4% | Price |
| 2025 | +26.2% | +21.8% | Price |
| 2026 to 13/11/2026 | +9.8% | +6.3% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 13.32% | -10.55% |
| 3 years | 12.00% | -10.55% |

## Largest fall

Volatility of Amundi Index Solutions - MSCI Europe UCITS ETF DR in pounds, annualised from weekly returns to 13/11/2026: 13.3% over 1 year, 12.0% over 3 years. Largest fall in the price of Amundi Index Solutions - MSCI Europe UCITS ETF DR since April 2022, in pounds: −10.6% from 27/02/2026 to 20/03/2026. The lowest 12-month return of Amundi Index Solutions - MSCI Europe UCITS ETF DR in pounds (price, with income reinvested in the fund) since April 2022 was +0.3% (12 months to 04/04/2025); the highest was +29.8% (12 months to 10/04/2026). On 13/11/2026 the price of Amundi Index Solutions - MSCI Europe UCITS ETF DR was 1.6% below its highest weekly close since April 2022 (07/08/2026), in pounds.

## Charges compared with similar funds

Ongoing charge of Amundi Index Solutions - MSCI Europe UCITS ETF DR 0.15% a year. Compared on 14/11/2026, 162 of the 242 other European share funds charge more, 13 the same and 67 less (share classes counted once).

## Funds tracking the same index

16 funds track MSCI Europe Index - EUR - Benchmark TR Net, this one included and share classes counted once; their ongoing charges range from 0.07% to 0.31% a year (13/11/2026).

| Fund | Ongoing charge | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Amundi Index Solutions - MSCI Europe UCITS ETF DR (this fund) | 0.15% | +10.5% | +52.7% | +55.4% |
| Amundi Index Solutions - MSCI Europe UCITS ETF DR Dist | 0.20% | +10.5% | +52.7% | +55.4% |
| BNP PARIBAS EASY MSCI EUROPE ETF Capitalisation -UCITS ETF- | 0.28% | +10.3% | — | — |
| Deka MSCI Europe UCITS ETF | 0.30% | +11.0% | +53.1% | +54.6% |
| HSBC MSCI Europe UCITS ETF Accum EUR | 0.14% | +11.4% | — | — |
| HSBC MSCI Europe UCITS ETF EUR | 0.14% | +11.4% | +54.2% | +55.8% |
| Invesco MSCI Europe UCITS ETF | 0.19% | +11.2% | +53.7% | +55.0% |
| iShares Core MSCI Europe UCITS ETF | 0.12% | +11.4% | +54.2% | +56.0% |
| iShares Core MSCI Europe UCITS ETF Accum Shs Hedged MXN | 0.17% | +16.4% | +64.6% | +145.0% |
| iShares Core MSCI Europe UCITS ETF EUR (Acc) | 0.12% | +11.4% | +54.3% | +56.0% |
| State Street SPDR MSCI Europe UCITS ETF | 0.25% | +10.5% | +52.5% | +54.9% |
| UBS (Lux) Fund Solutions SICAV - UBS Core MSCI Europe UCITS ETF EUR dis- Distribution | 0.07% | +10.6% | +53.0% | +55.6% |
| UBS Core MSCI Europe UCITS ETF Capitalisation A | 0.10% | +10.4% | — | — |
| Xtrackers MSCI EUROPE UCITS ETF Capitalisation 1C | 0.13% | +11.4% | +54.5% | +55.4% |
| Xtrackers MSCI EUROPE UCITS ETF Capitalisation 2C | 0.31% | +17.3% | +53.9% | +75.1% |
| Xtrackers MSCI EUROPE UCITS ETF Distribution 1D | 0.13% | +11.2% | +54.5% | +55.7% |

Returns are as reported, in pounds, income reinvested unless marked "(price)".

## Charges & eligibility

- Ongoing charges figure (OCF): **0.15%** per year
- Stocks and shares ISA eligible: usually (check with your platform)
- SIPP eligible: usually (check with your provider)
- ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify.

## What it holds

As of 11/11/2026, CEG2 holds 402 positions, according to its published holdings. The largest is ASML at 4.31% of the fund; the ten largest make up 21.6%.

### Top holdings

Largest positions (as of 11/11/2026), as a percentage of the whole fund:

| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | ASML | [ASML](https://fundology.uk/stock/ASML) | 4.31% |
| 2 | Roche | [RO](https://fundology.uk/stock/RO) | 2.42% |
| 3 | HSBC | [HSBA](https://fundology.uk/stock/HSBA) | 2.20% |
| 4 | Novartis | [NOVN](https://fundology.uk/stock/NOVN) | 2.08% |
| 5 | Shell | [SHEL](https://fundology.uk/stock/SHEL) | 2.01% |
| 6 | AstraZeneca | [AZN](https://fundology.uk/stock/AZN) | 1.99% |
| 7 | Nestle | [NESN](https://fundology.uk/stock/NESN) | 1.89% |
| 8 | SAP | [SAP](https://fundology.uk/stock/SAP) | 1.69% |
| 9 | Siemens | [SIE](https://fundology.uk/stock/SIE) | 1.58% |
| 10 | Allianz | [ALV](https://fundology.uk/stock/ALV) | 1.39% |

## Where it invests

Shares of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.

### By sector

As published for the fund, as of 11/11/2026.

| Sector | Weight |
|---|---|
| Financials | 24.8% |
| Industrials | 17.9% |
| Health Care | 14.1% |
| Consumer Staples | 9.0% |
| Information Technology | 8.7% |
| Consumer Discretionary | 6.1% |
| Materials | 5.4% |
| Energy | 5.3% |
| Other sectors | 8.7% |

### By country

As published for the fund, as of 11/11/2026.

| Country | Weight |
|---|---|
| United Kingdom | 22.5% |
| Switzerland | 15.1% |
| France | 14.8% |
| Germany | 13.7% |
| Netherlands | 8.5% |
| Spain | 6.2% |
| Sweden | 5.5% |
| Italy | 5.0% |
| Other countries | 8.8% |

The 395 holdings on record (of 402 reported): https://fundology.uk/fund/ceg2/holdings

## Questions people ask

**What is the ongoing charge of CEG2?**

The ongoing charge of CEG2 is 0.15% a year — about £15 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Amundi Index Solutions - MSCI Europe UCITS ETF DR 0.15% a year. Compared on 14/11/2026, 162 of the 242 other European share funds charge more, 13 the same and 67 less (share classes counted once).

**What does CEG2 track?**

CEG2 tracks the MSCI Europe Index - EUR - Benchmark TR Net — large and medium-sized European companies.

**Is CEG2 accumulating or distributing?**

CEG2 is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

**What is the ISIN of CEG2?**

The ISIN of CEG2 is LU1437015735. An ISIN identifies one exact share class of a fund; CEG2 is its ticker on the London Stock Exchange. The same share class is also listed as CEU2 (London Stock Exchange, US dollars).

**What does CEG2 hold?**

As of 11/11/2026, CEG2 holds 402 positions, according to its published holdings. The largest is ASML at 4.31% of the fund; the ten largest make up 21.6%. Its ten largest holdings are ASML (4.31%), Roche (2.42%), HSBC (2.20%), Novartis (2.08%), Shell (2.01%), AstraZeneca (1.99%), Nestle (1.89%), SAP (1.69%), Siemens (1.58%) and Allianz (1.39%).

**What were CEG2’s returns in each of the last five years?**

Calendar-year returns of CEG2 in pounds (price, with income reinvested in the fund): 2023 +13.2%, 2024 +4.0%, 2025 +26.2%; 2026 to 13/11/2026 +9.8%. Past performance is not a guide to future returns.

**How has CEG2 done after inflation?**

Over the five years to 13/11/2026 CEG2’s total return was +55.4%, or +21.3% after UK CPIH inflation. Past performance is not a guide to future returns.

## Fund documents

- [Fund page at Amundi](https://www.amundietf.co.uk/en/professional/products/equity/amundi-core-msci-europe-ucits-etf-acc/lu1437015735)
- Links checked 12/10/2026.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.